PRADER-WILLI SYNDROME
Clinical trials for PRADER-WILLI SYNDROME explained in plain language.
Never miss a new study
Get alerted when new PRADER-WILLI SYNDROME trials appear
Sign up with your email to follow new studies for PRADER-WILLI SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial targets uncontrollable hunger in rare genetic disorder
Disease control Not yet recruitingThis early-stage study is testing an investigational drug called CSTI-500 in people with Prader-Willi syndrome, a rare genetic disorder that causes constant hunger and behavioral challenges. The main goals are to check if the drug is safe and to find the right dose for each perso…
Matched conditions: PRADER-WILLI SYNDROME
Phase: PHASE2 • Sponsor: ConSynance Therapeutics • Aim: Disease control
Last updated Mar 10, 2026 12:53 UTC
-
New drug trial targets uncontrollable hunger in rare genetic disorder
Symptom relief Not yet recruitingThis study is testing whether a new oral medication called BMB-101 can safely reduce the severe, constant hunger experienced by adults with Prader-Willi Syndrome (PWS). Sixteen participants will be randomly assigned to receive either the real drug or a placebo for 16 weeks, follo…
Matched conditions: PRADER-WILLI SYNDROME
Phase: PHASE2 • Sponsor: Bright Minds Biosciences Pty Ltd • Aim: Symptom relief
Last updated Mar 18, 2026 14:41 UTC